New Targeted Drugs Improve Survival in Advanced Prostate Cancer
Two experimental targeted drugs — radium–223 chloride and MDV3100 — helped some men with difficult–to–treat prostate cancer live longer compared to standard care, according to two international studies.
| • | NCI Cancer Bulletin: new drugs for prostate cancer |
| • | Learn more about prostate cancer treatment |
| • | Targeted Cancer Therapies fact sheet |
Cancer Research News
- Duke study finds heart disease may be a risk factor for prostate cancer
- UC Davis study shows how DNA finds its match
- USC study finds fasting weakens cancer in mice
Visit the NCI News Center







